IperionX ramps up titanium production, secures US government support

The IperionX Ltd (ASX: IPX) share price is in focus after the company completed commissioning of its Virginia Titanium Manufacturing Campus and ended the December quarter with a strong US$65.8 million cash balance.

What did IperionX report?

• Equipment for titanium powder and component production fully commissioned at the Virginia Titanium Manufacturing Campus
• Manufacturing capacity expansion on track, with target of 1,400 tons per annum (tpa) by 2027
• Initial sales orders received from Carver Pump and American Rheinmetall for titanium components
• US$47.1 million US Department of War grant fully obligated, aiding expansion plans
• US$65.8 million in cash at quarter-end, with US$46.5 million in grant funding still available
• ISO 9001 quality certification achieved for manufacturing operations

What else do investors need to know?

The company has commenced building inventory for mass distribution, including a range of titanium fasteners for commercial and U.S. military customers. IperionX continues advanced prototyping for industries like defense, electronics, automotive, and oil & gas, highlighting growing commercial activity.

Progress was also made at the Titan Critical Minerals Project in Tennessee. Backed by U.S. Government interest and funding, IperionX aims to help address the nation’s supply gap for critical minerals, including heavy rare earths and titanium needed in defence and clean energy applications.

Federal Government support remains a key pillar, with the U.S. transferring around 290 tons of titanium scrap to IperionX at no cost, securing feedstock for about 1.5 years at current capacity.

What’s next for IperionX?

IperionX plans to scale titanium production to 1,400 tpa by 2027, targeting market leadership as America’s largest and lowest-cost titanium powder producer. Additional presses and furnaces arriving in 2026 will support this capacity ramp-up.

The company is also piloting next-generation, continuous titanium production technology, aiming for completion in 2026. Meanwhile, a Definitive Feasibility Study for the Titan Critical Minerals Project remains on schedule, with completion targeted for mid-2026.

IperionX share price snapshot

Over the past 12 months, IperionX shares have risen 90% outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 5% over the same period.

View Original Announcement

The post IperionX ramps up titanium production, secures US government support appeared first on The Motley Fool Australia.

More reading

• Nickel Industries cements leadership in ENC, welcomes Sphere as strategic partner
• Emerald Resources delivers strong December quarter with growth across Australia and Cambodia
• Atlas Arteria shares: Q4 2025 toll revenue jumps 9.5%
• Elders FY25 earnings: resilient profit and strategic growth
• Resmed posts Q2 FY26 earnings growth, lifts dividend

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.